(Total Views: 243)
Posted On: 03/29/2022 10:46:00 AM
Post# of 97
$IMGN News Article - ImmunoGen Submits Biologics License Application to the US Food and Drug Administration for Mirvetuximab Soravtansine in Ovarian Cancer https://marketwirenews.com/news-releases/immu...93495.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
